Volver a Agenda
Session 17: Common Technical Document - Module 3
Session Chair(s)
Albert S. Yehaskel, MBA
President and CEO
Refuah Global Pharmaceutical Development, Inc., United States
- Content and Requirements
¿Tiene una cuenta?
Already a DIA Member? Sign in. Not a member? Join.
Iniciar sesión
DIA Global Center
15 oct 2018 8:15 a.m. - 16 oct 2018 3:30 p.m.
21 Dupont Circle NW, Suite 300, Washington, DC 20036